Literature DB >> 21326787

Clinical care of patients undergoing uterine artery embolization.

Thuong G Van Ha1, Natasha Li.   

Abstract

Uterine artery embolization (UAE) is a relatively recent, safe, and minimally invasive procedure for women experiencing symptomatic fibroids. This process of percutaneous occlusion of blood vessels to disrupt blood flow will consequently impede nourishment to the uterine fibroids and cause infarction. To have proper patient treatment to optimize overall clinical success, guidelines should be rigorously followed. This article will delineate a suitable patient care process for UAE in which subsequent interventional radiologists can employ.

Entities:  

Keywords:  Fibroids; patient care; uterine artery embolization; uterine fibroid embolization

Year:  2006        PMID: 21326787      PMCID: PMC3036391          DOI: 10.1055/s-2006-957025

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  34 in total

1.  Uterine arteries: bilateral catheterization with a single femoral approach and a single 5-F catheter--technical note.

Authors:  J P Pelage; P Soyer; O Le Dref; H Dahan; J Coumbaras; M Kardache; R Rymer
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

Review 2.  Uterine myomas: an overview of development, clinical features, and management.

Authors:  Edward E Wallach; Nikos F Vlahos
Journal:  Obstet Gynecol       Date:  2004-08       Impact factor: 7.661

Review 3.  Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy.

Authors:  Jay Goldberg; Leonardo Pereira
Journal:  Curr Opin Obstet Gynecol       Date:  2006-08       Impact factor: 1.927

4.  Risk of intrauterine infectious complications after uterine artery embolization.

Authors:  Dheeraj K Rajan; John R Beecroft; Timothy W I Clark; Murray R Asch; Martin E Simons; John R Kachura; Michael Sved; Kenneth W Sniderman
Journal:  J Vasc Interv Radiol       Date:  2004-12       Impact factor: 3.464

5.  Review of readmissions due to complications from uterine fibroid embolization.

Authors:  H Mehta; C Sandhu; M Matson; A-M Belli
Journal:  Clin Radiol       Date:  2002-12       Impact factor: 2.350

6.  Uterine artery embolization in the treatment of symptomatic uterine fibroid tumors (EMMY trial): periprocedural results and complications.

Authors:  Nicole A Volkers; Wouter J K Hehenkamp; Erwin Birnie; Cees de Vries; Cor Holt; Willem M Ankum; Jim A Reekers
Journal:  J Vasc Interv Radiol       Date:  2006-03       Impact factor: 3.464

7.  Uterine artery embolization for the treatment of uterine leiomyomata midterm results.

Authors:  S C Goodwin; B McLucas; M Lee; G Chen; R Perrella; S Vedantham; S Muir; A Lai; J W Sayre; M DeLeon
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

8.  Uterine artery embolization for pedunculated subserosal fibroids.

Authors:  Tetsuya Katsumori; Kentarou Akazawa; Tadashi Mihara
Journal:  AJR Am J Roentgenol       Date:  2005-02       Impact factor: 3.959

9.  Clinical pathway for evaluating women with abnormal uterine bleeding.

Authors:  T S Dunn; C A Stamm; M Delorit; G Goldberg
Journal:  J Reprod Med       Date:  2001-09       Impact factor: 0.142

10.  Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial.

Authors:  Gaylene Pron; Eva Mocarski; John Bennett; George Vilos; Andrew Common; Mukarram Zaidi; Kenneth Sniderman; Murray Asch; Roman Kozak; Martin Simons; Cuong Tran; John Kachura
Journal:  J Vasc Interv Radiol       Date:  2003-10       Impact factor: 3.464

View more
  1 in total

Review 1.  Uterine fibroid therapy using interventional radiology mini-invasive treatments: current perspective.

Authors:  Carlo Masciocchi; Francesco Arrigoni; Fabiana Ferrari; Aldo Victor Giordano; Sonia Iafrate; Ilaria Capretti; Ester Cannizzaro; Alfonso Reginelli; Anna Maria Ierardi; Chiara Floridi; Alessio Salvatore Angileri; Luca Brunese; Antonio Barile
Journal:  Med Oncol       Date:  2017-02-24       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.